PT Bio Farma
PT Bio Farma
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Interchangeability Hep-B Vaccine Administered at Birth Dose | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 3 | 2026-10-02 | NCT07854847 | |
| Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 3 | 2026-09-17 | NCT07824310 | |
| A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Phase 1 | 2026-06-15 | NCT07647107 | |
| Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-05-11 | NCT05654467 | |
| Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-01-09 | NCT06895486 | |
| Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III) | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 3 | 2025-06-06 | NCT05482295 | |
| Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV | Antibody Typhoid Vaccine | Not yet recruiting | Not stated | 2025-06-03 | NCT06921460 | |
| Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants | Vaccine Adverse Reaction; Vaccine Reaction | Not yet recruiting | Phase 1 / Phase 2 | 2024-11-15 | NCT06690515 |